Source: BioSpace

Iconic Therapeutics: Iconic Therapeutics Signs Ophthalmology Option Agreement

Upfront payment and equity investment made to secure option on antibody for ophthalmology

Read full article »
Iconic Therapeutics's Competitors | Iconic Therapeutics's News | Iconic Therapeutics's Financials
Stay up-to-date with the latest news on Iconic Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
William L. Greene's photo - CEO of Iconic Therapeutics

CEO

William L. Greene

CEO Approval Rating

77/100

Read more
Stay up-to-date with the latest news on Iconic Therapeutics